Endocrinology, Vol 128, 1474-1480, Copyright © 1991 by Endocrine Society

ARTICLES

Transcriptional regulation of ferritin messenger ribonucleic acid levels by insulin in cultured rat glioma cells

N Yokomori, Y Iwasa, K Aida, M Inoue, M Tawata and T Onaya
Third Department of Internal Medicine, University of Yamanashi Medical School, Japan.

Recent data have shown that ferritin, a ubiquitous protein, has a role as a regulator of cellular differentiation. In the present study we have investigated the expression of ferritin mRNAs in cultured C6 cells, a rat glioma cell line, in response to insulin, which has an important role in cellular growth and differentiation. Insulin stimulated steady state levels of both ferritin heavy chain and ferritin light chain mRNAs. An increase in the level of ferritin heavy or light chain mRNA was detected after 2 h of incubation with insulin, and a plateau was reached after 48 h for heavy chain mRNA and after 72 h for light chain mRNA. The responses were dose-dependent and were maximal at 100 nM for both mRNAs. Treatment of cells with actinomycin-D showed that insulin had no effect on the posttranscriptional stability of these mRNAs. Actinomycin-D inhibited insulin-induced accumulation of both mRNAs, suggesting transcriptional stimulation of ferritin genes by insulin. A nuclear run-on assay showed that the insulin-induced increase in ferritin heavy chain mRNA was due to an increase in the rate of gene transcription. We also demonstrated that insulin-like growth factor-I (IGF-I) increased ferritin heavy and light chain mRNA levels in a dose-dependent fashion, and that the maximum effect was obtained at a concentration of 10 nM on both mRNA levels. IGF-I was not only 10-fold more potent, but the absolute level of maximum stimulation was also about 2-fold greater than that for insulin. The combination of insulin (100 nM) and IGF-I (10 nM) showed no additive effect. The results suggested that the ferritin heavy and light chain genes are transcriptionally regulated by insulin and influenced by IGF-I.

This article has been cited by other articles:

				M. L. Jehn, E. Guallar, J. M. Clark, D. Couper, B. B. Duncan, C. M. Ballantyne, R. C. Hoogeveen, Z. L. Harris, and J. S. Pankow A Prospective Study of Plasma Ferritin Level and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study Am. J. Epidemiol., May 1, 2007; 165(9): 1047 - 1054. [Abstract] [Full Text] [PDF]

				J. M. Fernandez-Real, J. M. Moreno, A. Lopez-Bermejo, B. Chico, J. Vendrell, and W. Ricart Circulating Soluble Transferrin Receptor According to Glucose Tolerance Status and Insulin Sensitivity Diabetes Care, March 1, 2007; 30(3): 604 - 608. [Abstract] [Full Text] [PDF]

				R. Li, C. Luo, M. Mines, J. Zhang, and G.-H. Fan Chemokine CXCL12 Induces Binding of Ferritin Heavy Chain to the Chemokine Receptor CXCR4, Alters CXCR4 Signaling, and Induces Phosphorylation and Nuclear Translocation of Ferritin Heavy Chain J. Biol. Chem., December 8, 2006; 281(49): 37616 - 37627. [Abstract] [Full Text] [PDF]

				J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart Cross-Talk Between Iron Metabolism and Diabetes Diabetes, August 1, 2002; 51(8): 2348 - 2354. [Abstract] [Full Text] [PDF]

				F. M. Torti and S. V. Torti Regulation of ferritin genes and protein Blood, May 15, 2002; 99(10): 3505 - 3516. [Full Text] [PDF]

				M. A. Bevilacqua, M. C. Faniello, B. Quaresima, M. T. Tiano, P. Giuliano, A. Feliciello, V. E. Avvedimento, F. Cimino, and F. Costanzo A Common Mechanism Underlying the E1A Repression and the cAMP Stimulation of the H Ferritin Transcription J. Biol. Chem., August 15, 1997; 272(33): 20736 - 20741. [Abstract] [Full Text] [PDF]

				H. Shimura, K. Haraguchi, T. Endo, and T. Onaya Regulation of Thyrotropin Receptor Gene Expression in 3T3-L1 Adipose Cells is Distinct from Its Regulation in FRTL-5 Thyroid Cells Endocrinology, April 1, 1997; 138(4): 1483 - 1490. [Abstract] [Full Text] [PDF]